FLJ40125 Inhibitors
The chemical class of FLJ40125 Inhibitors consists of various compounds that can potentially inhibit the activity of the FLJ40125 protein by targeting signaling pathways in which it is involved. FLJ40125 is likely associated with phosphoinositide 3-kinase (PI3K) and mechanistic target of rapamycin (mTOR) signaling pathways, which play crucial roles in cell growth, survival, and proliferation.
Direct inhibitors such as GDC-0941, BKM120, AZD5363, MK-2206, BEZ235, GSK2110183, PI-103, PF-04691502, rapamycin, Torin1, OSI-027, and temsirolimus target key components or regulators of these pathways, potentially disrupting FLJ40125-mediated cellular functions. By inhibiting the activity of these signaling molecules, these compounds can interfere with downstream signaling cascades involving FLJ40125, thereby modulating its function indirectly. Understanding the interplay between FLJ40125 and these signaling pathways is crucial for elucidating its physiological roles and may provide insights into strategies for diseases associated with dysregulated FLJ40125 signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a selective inhibitor of phosphoinositide 3-kinase (PI3K) targeting the p110α isoform. FLJ40125 may be involved in PI3K signaling pathways, and inhibition of PI3K by GDC-0941 can disrupt downstream signaling cascades, potentially inhibiting the function of FLJ40125. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $176.00 $235.00 $281.00 $339.00 | 9 | |
BKM120 is a potent and selective inhibitor of pan-class I PI3Ks, targeting the p110α isoform. By blocking PI3K activity, BKM120 can interfere with signaling pathways involving FLJ40125, potentially inhibiting its function. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363 is a selective inhibitor of AKT, a downstream effector of PI3K signaling. Inhibition of AKT by AZD5363 can disrupt downstream signaling cascades involving FLJ40125, potentially inhibiting its cellular functions. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is a selective inhibitor of AKT, a key component of the PI3K signaling pathway. Inhibition of AKT by MK-2206 can disrupt downstream signaling pathways involving FLJ40125, potentially inhibiting its cellular functions. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
BEZ235 is a dual inhibitor of PI3K and mTOR, targeting the catalytic subunits of these enzymes. FLJ40125 may interact with PI3K and mTOR signaling pathways, and inhibition of both enzymes by BEZ235 can disrupt downstream signaling cascades, potentially inhibiting the function of FLJ40125. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a dual inhibitor of PI3K and mTOR, targeting their catalytic subunits. FLJ40125 may be involved in PI3K and mTOR signaling pathways, and inhibition of both enzymes by PI-103 can disrupt downstream signaling cascades, potentially inhibiting the function of FLJ40125. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mechanistic target of rapamycin (mTOR), a key regulator of cell growth and proliferation. FLJ40125 may be involved in mTOR signaling pathways, and inhibition of mTOR by rapamycin can disrupt downstream signaling cascades, potentially inhibiting the function of FLJ40125. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin1 is a potent and selective inhibitor of mTOR, targeting both mTORC1 and mTORC2 complexes. By inhibiting mTOR activity, Torin1 can interfere with signaling pathways involving FLJ40125, potentially inhibiting its cellular functions. | ||||||
OSI-027 | 936890-98-1 | sc-364557 sc-364557A | 10 mg 50 mg | $437.00 $1186.00 | 1 | |
OSI-027 is a selective inhibitor of mTORC1 and mTORC2 complexes. FLJ40125 may interact with mTOR signaling pathways, and inhibition of mTOR by OSI-027 can disrupt downstream signaling cascades, potentially inhibiting the function of FLJ40125. | ||||||